Dr. John W. Waggoner

Satyavardhan Pulukurthy, MD, FACC, FSCAI, is a cardiologist with board certifications in cardiology, interventional cardiology and internal medicine. Dr. Pulukurthy strives to treat all of his patients with skill and compassion, listening to their concerns and providing a customized care plan. He likes to put his patients at ease by being friendly and approachable, and ensuring them that his knowledge and expertise will help achieve excellent outcomes.Given his broad knowledge and multi-specialty background, he prefers to treat his patients using a comprehensive approach considering the interrelationship of both the cardiac and vascular systems. Dr. Pulukurthy believes that aggressive treatment of risk factors achieves immense reduction in cardiovascular disease, incorporating the principle of prevention is better than a cure. Dr. Pulukurthy is rated as a Distinguished provider by MediFind in the treatment of Familial Neurocardiogenic Syncope. His top areas of expertise are Heart Attack, Angina, Coronary Heart Disease, Pacemaker Implantation, and Angioplasty.

Richard Kennedy is a Cardiologist in Olympia,, Washington. Dr. Kennedy is rated as a Distinguished provider by MediFind in the treatment of Familial Neurocardiogenic Syncope. His top areas of expertise are Metabolic Syndrome, Atrial Fibrillation, Familial Neurocardiogenic Syncope, and Angina.

"Mariko Harper, MD, FACC is a board-certified cardiologist who specializes in all aspects of adult cardiology including: coronary artery disease, hyperlipidemia, valvular heart disease, arrhythmias, genetic/infiltrative cardiomyopathy, hypertrophic cardiomyopathy (HCM) and heart failure. She has a special expertise in advanced heart failure and advanced cardiac imaging with additional training and board certifications in both echocardiography and nuclear cardiology.Dr. Harper serves as the Medical Director of The Hypertrophic Cardiomyopathy Center at Virginia Mason Franciscan Health. Under her direction, she has created a regional center providing an individualized approach to the diagnosis, genetic testing, advanced cardiac imaging and medical/surgical management of patients with HCM. Each patient is reviewed by a multidisciplinary team of physicians and treatment plans are designed with patient input, using a shared decision making model. The HCM Center offers comprehensive HCM treatments including: medical therapy, defibrillator implantation, alcohol septal ablation and surgical septal myectomy. The HCM Center is also one of the first centers in the PNW to offer the recently FDA-approved novel HCM medication mavacamten through a comprehensive drug safety program. She also serves as a principal investigator for ongoing HCM clinical trials.Dr. Harper has authored and published multiple peer reviewed articles and book chapters in a wide range of topics in cardiology. She has been an invited speaker at both national and regional meetings on topics including hypertrophic cardiomyopathy, hyperlipidemia, and preventive cardiology. Following her passion for patient education and cardiovascular disease prevention, she is also one of the course directors for the ""Food Is Medicine"" continuing medical education lecture series at Virginia Mason Franciscan Health. Dr. Harper believes in patient-centered and patient-driven care. She emphasizes the importance of shared clinical decision making, with open dialogue between the patient and the entirety of the patient's multidisciplinary care team.Dr. Harper has been recognized as aSeattle MetTop Doctor in 2021 and 2022.In her free time, she enjoys reading, gardening, running and spending time with her family.". Dr. Harper is rated as a Distinguished provider by MediFind in the treatment of Familial Neurocardiogenic Syncope. Her top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Heart Failure with Preserved Ejection Fraction (HFpEF), Familial Hypertrophic Cardiomyopathy, and Cardiomyopathy.